3-D Mammography Sends Hologic Skyrocketing

Chris Newmarker

December 17, 2015

2 Min Read
3-D Mammography Sends Hologic Skyrocketing

FDA-approved Genius 3D mammography systems played a major role in Hologic's stellar growth this year.

Chris Newmarker

Mammography innovation has been driving stellar growth for Hologic, which saw its stock value rise 46% through much of 2015. The Bedford, MA-based medtech company says it has been seeing accelerated adoption of its FDA-approved Genius 3D mammography systems, with breast imaging and services up 26% during the fourth quarter alone. Hologic boasts that the 3-D imaging is able to detect 41% more invasive cancers than standard 2-D imaging.

About 2400 3-D systems have shipped so far in the United States. "While we are making excellent progress, this represents less than 30% of our own domestic mammography installed base, so we have a long runway still ahead of us before the market fully converts to 3-D. We have also installed roughly 1200 Genius systems in international markets, so our global installed base is now approximately 3600," CEO Stephen MacMillan said in a November 4 earnings call transcribed by Seeking Alpha.

Hologic's diagnostics and surgical businesses are also showing broad-based strength, according to the company. For the fiscal year ended September 26, Hologic earned $132 million off $2.7 billion in sales, up from $17 million in profits off $2.5 billion in sales a year before.

Indeed, Philips may have been jealous at Hologic's fortunes. In April, Philips hired Hologic's then CEO Robert Cascella to lead its medical technology business. Cascella had helped the company increase its annual revenue by nearly $1 billion in four years.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like